Didem Saygin to Adult
This is a "connection" page, showing publications Didem Saygin has written about Adult.
Connection Strength
0.775
-
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clin Exp Rheumatol. 2024 Feb; 42(2):403-412.
Score: 0.097
-
Serum cytokine profiles of adults with idiopathic inflammatory myopathies. Clin Exp Rheumatol. 2024 Feb; 42(2):229-236.
Score: 0.096
-
Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group. Semin Arthritis Rheum. 2024 Feb; 64:152339.
Score: 0.095
-
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. Rheumatology (Oxford). 2023 Nov 02; 62(11):3672-3679.
Score: 0.094
-
Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies. Curr Rheumatol Rep. 2022 Mar; 24(3):54-63.
Score: 0.084
-
Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy. Semin Arthritis Rheum. 2021 Jun; 51(3):539-546.
Score: 0.079
-
Differentiation between neurosarcoidosis and primary central nervous system vasculitis based on demographic, cerebrospinal and imaging features. Clin Exp Rheumatol. 2020; 38 Suppl 124(2):135-138.
Score: 0.072
-
Tattoo reaction as a presenting manifestation of systemic sarcoidosis. Rheumatology (Oxford). 2019 May 01; 58(5):927.
Score: 0.069
-
Collaborative research in myositis-related disorders: MIHRA, a global shared community model. Clin Exp Rheumatol. 2024 Feb; 42(2):207-212.
Score: 0.024
-
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy. Rheumatology (Oxford). 2023 Dec 01; 62(12):3957-3961.
Score: 0.024
-
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group. Semin Arthritis Rheum. 2023 Feb; 58:152111.
Score: 0.022
-
Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide. Rheumatology (Oxford). 2020 Sep 01; 59(9):2264-2271.
Score: 0.019